Marchais-Oberwinkler S, Henn C, Moller G, Klein T, Negri M, Oster A, et al. 17beta-Hydroxysteroid dehydrogenases (17beta-HSDs) as therapeutic targets: protein structures, functions, and recent progress in inhibitor development. J Steroid Biochem Mol Biol. 2011;125(1–2):66–82.
Wang MX, Peng ZG. 17beta-hydroxysteroid dehydrogenases in the progression of nonalcoholic fatty liver disease. Pharmacol Ther. 2023;246:108428.
Peltoketo H, Isomaa V, Maentausta O, Vihko R. Complete amino acid sequence of human placental 17 beta-hydroxysteroid dehydrogenase deduced from cDNA. FEBS Lett. 1988;239(1):73–7.
The VL, Labrie C, Zhao HF, Couët J, Lachance Y, Simard J, et al. Characterization of cDNAs for human estradiol 17β-Dehydrogenase and assignment of the gene to chromosome 17: evidence of two mRNA species with distinct 5′-Termini in human placenta. Mol Endocrinol. 1989;3(8):1301–9.
Rotinen M, Villar J, Encio I. Regulation of 17beta-hydroxysteroid dehydrogenases in cancer: regulating steroid receptor at pre-receptor stage. J Physiol Biochem. 2012;68(3):461–73.
Poutanen M, Hagberg Thulin M, Härkönen P. Targeting sex steroid biosynthesis for breast and prostate cancer therapy. Nat Rev Cancer. 2023.
Szklarczyk D, Kirsch R, Koutrouli M, Nastou K, Mehryary F, Hachilif R, et al. The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. 2023;51(D1):D638–46.
Puranen T, Poutanen M, Ghosh D, Vihko P, Vihko R. Characterization of structural and functional properties of human 17 beta-hydroxysteroid dehydrogenase type 1 using Recombinant enzymes and site-directed mutagenesis. Mol Endocrinol. 1997;11(1):77–86.
Wu L, Einstein M, Geissler WM, Chan HK, Elliston KO, Andersson S. Expression cloning and characterization of human 17 beta-hydroxysteroid dehydrogenase type 2, a microsomal enzyme possessing 20 alpha-hydroxysteroid dehydrogenase activity. J Biol Chem. 1993;268(17):12964–9.
Lu ML, Huang YW, Lin SX. Purification, reconstitution, and steady-state kinetics of the trans-membrane 17 beta-hydroxysteroid dehydrogenase 2. J Biol Chem. 2002;277(25):22123–30.
Puranen TJ, Kurkela RM, Lakkakorpi JT, Poutanen MH, Itäranta PV, Melis JP, et al. Characterization of molecular and catalytic properties of intact and truncated human 17beta-hydroxysteroid dehydrogenase type 2 enzymes: intracellular localization of the wild-type enzyme in the Endoplasmic reticulum. Endocrinology. 1999;140(7):3334–41.
Engeli RT, Rhouma BB, Sager CP, Tsachaki M, Birk J, Fakhfakh F et al. Biochemical analyses and molecular modeling explain the functional loss of 17β-hydroxysteroid dehydrogenase 3 mutant G133R in three Tunisian patients with 46, XY disorders of sex development. J Steroid Biochem Mol Biol. 2016; 155(Pt A):147– 54.
Mindnich R, Haller F, Halbach F, Moeller G, Hrabé de Angelis M, Adamski J. Androgen metabolism via 17beta-hydroxysteroid dehydrogenase type 3 in mammalian and non-mammalian vertebrates: comparison of the human and the zebrafish enzyme. J Mol Endocrinol. 2005;35(2):305–16.
Ferlin A, Ganz F, Pengo M, Selice R, Frigo AC, Foresta C. Association of testicular germ cell tumor with polymorphisms in Estrogen receptor and steroid metabolism genes. Endocr Relat Cancer. 2010;17(1):17–25.
Ferdinandusse S, Denis S, van Berkel E, Dacremont G, Wanders RJ. Peroxisomal fatty acid oxidation disorders and 58 kda sterol carrier protein X (SCPx). Activity measurements in liver and fibroblasts using a newly developed method. J Lipid Res. 2000;41(3):336–42.
Jiang LL, Miyazawa S, Souri M, Hashimoto T. Structure of D-3-hydroxyacyl-CoA dehydratase/D-3-hydroxyacyl-CoA dehydrogenase bifunctional protein. J Biochem. 1997;121(2):364–9.
Ferdinandusse S, Denis S, Van Roermund CW, Wanders RJ, Dacremont G. Identification of the peroxisomal beta-oxidation enzymes involved in the degradation of long-chain Dicarboxylic acids. J Lipid Res. 2004;45(6):1104–11.
van Grunsven EG, van Berkel E, Ijlst L, Vreken P, de Klerk JB, Adamski J, et al. Peroxisomal D-hydroxyacyl-CoA dehydrogenase deficiency: resolution of the enzyme defect and its molecular basis in bifunctional protein deficiency. Proc Natl Acad Sci U S A. 1998;95(5):2128–33.
PubMed PubMed Central Google Scholar
Suzuki-Yamamoto T, Nishizawa M, Fukui M, Okuda-Ashitaka E, Nakajima T, Ito S, et al. cDNA cloning, expression and characterization of human prostaglandin F synthase. FEBS Lett. 1999;462(3):335–40.
Byrns MC, Duan L, Lee SH, Blair IA, Penning TM. Aldo-keto reductase 1C3 expression in MCF-7 cells reveals roles in steroid hormone and prostaglandin metabolism that May explain its over-expression in breast cancer. J Steroid Biochem Mol Biol. 2010;118(3):177–87.
Penning TM, Burczynski ME, Jez JM, Hung CF, Lin HK, Ma H, et al. Human 3alpha-hydroxysteroid dehydrogenase isoforms (AKR1C1-AKR1C4) of the aldo-keto reductase superfamily: functional plasticity and tissue distribution reveals roles in the inactivation and formation of male and female sex hormones. Biochem J. 2000;351(Pt 1):67–77.
CAS PubMed PubMed Central Google Scholar
Ruiz FX, Porté S, Gallego O, Moro A, Ardèvol A, Del Río-Espínola A, et al. Retinaldehyde is a substrate for human aldo-keto reductases of the 1 C subfamily. Biochem J. 2011;440(3):335–44.
Huang XF, Luu-The V. Molecular characterization of a first human 3(alpha–>beta)-hydroxysteroid epimerase. J Biol Chem. 2000;275(38):29452–7.
Chetyrkin SV, Hu J, Gough WH, Dumaual N, Kedishvili NY. Further characterization of human microsomal 3alpha-hydroxysteroid dehydrogenase. Arch Biochem Biophys. 2001;386(1):1–10.
Huang XF, Luu-The V. Gene structure, chromosomal localization and analysis of 3-ketosteroid reductase activity of the human 3(alpha–>beta)-hydroxysteroid epimerase. Biochim Biophys Acta. 2001;1520(2):124–30.
Taramino S, Teske B, Oliaro-Bosso S, Bard M, Balliano G. Divergent interactions involving the oxidosqualene cyclase and the steroid-3-ketoreductase in the sterol biosynthetic pathway of mammals and yeasts. Biochim Biophys Acta. 2010;1801(11):1232–7.
CAS PubMed PubMed Central Google Scholar
Bellavance E, Luu-The V, Poirier D. Potent and selective steroidal inhibitors of 17beta-hydroxysteroid dehydrogenase type 7, an enzyme that catalyzes the reduction of the key hormones estrone and dihydrotestosterone. J Med Chem. 2009;52(23):7488–502.
Törn S, Nokelainen P, Kurkela R, Pulkka A, Menjivar M, Ghosh S, et al. Production, purification, and functional analysis of Recombinant human and mouse 17beta-hydroxysteroid dehydrogenase type 7. Biochem Biophys Res Commun. 2003;305(1):37–45.
Härkönen P, Törn S, Kurkela R, Porvari K, Pulkka A, Lindfors A, et al. Sex hormone metabolism in prostate cancer cells during transition to an androgen-independent state. J Clin Endocrinol Metab. 2003;88(2):705–12.
Venkatesan R, Sah-Teli SK, Awoniyi LO, Jiang G, Prus P, Kastaniotis AJ, et al. Insights into mitochondrial fatty acid synthesis from the structure of heterotetrameric 3-ketoacyl-ACP reductase/3R-hydroxyacyl-CoA dehydrogenase. Nat Commun. 2014;5:4805.
Ohno S, Nishikawa K, Honda Y, Nakajin S. Expression in E. coli and tissue distribution of the human homologue of the mouse Ke 6 gene, 17beta-hydroxysteroid dehydrogenase type 8. Mol Cell Biochem. 2008;309(1–2):209–15.
Wang J, Chai X, Eriksson U, Napoli JL. Activity of human 11-cis-retinol dehydrogenase (Rdh5) with steroids and retinoids and expression of its mRNA in extra-ocular human tissue. Biochem J. 1999;338(Pt 1):23–7.
CAS PubMed PubMed Central Google Scholar
Fiandalo MV, Stocking JJ, Pop EA, Wilton JH, Mantione KM, Li Y, et al. Inhibition of dihydrotestosterone synthesis in prostate cancer by combined frontdoor and backdoor pathway Blockade. Oncotarget. 2018;9(13):11227–42.
PubMed PubMed Central Google Scholar
Mertz JR, Shang E, Piantedosi R, Wei S, Wolgemuth DJ, Blaner WS. Identification and characterization of a stereospecific human enzyme that catalyzes 9-cis-retinol oxidation. A possible role in 9-cis-retinoic acid formation. J Biol Chem. 1997;272(18):11744–9.
Reinhard L, Sridhara S, Hällberg BM. The MRPP1/MRPP2 complex is a tRNA-maturation platform in human mitochondria. Nucleic Acids Res. 2017;45(21):12469–80.
CAS PubMed PubMed Central Google Scholar
Shafqat N, Marschall HU, Filling C, Nordling E, Wu XQ, Björk L, et al. Expanded substrate screenings of human and Drosophila type 10 17beta-hydroxysteroid dehydrogenases (HSDs) reveal multiple specificities in bile acid and steroid hormone metabolism: characterization of multifunctional 3alpha/7alpha/7beta/17beta/20beta/21-HSD. Biochem J. 2003;376(Pt 1):49–60.
CAS PubMed PubMed Central Google Scholar
He XY, Schulz H, Yang SY. A human brain L-3-hydroxyacyl-coenzyme A dehydrogenase is identical to an amyloid beta-peptide-binding protein involved in alzheimer’s disease. J Biol Chem. 1998;273(17):10741–6.
Comments (0)